Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06429735 · ClinicalTrials.gov registry record · NA
Precise Robotically IMplanted Brain-Computer InterfacE
A NA study of Amyotrophic Lateral Sclerosis and Cervical Spinal Cord Injury, sponsored by Neuralink.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 2
- Study locations
NCT06429735: Recruiting NA study of Amyotrophic Lateral Sclerosis and Cervical Spinal Cord Injury, sponsored by Neuralink.
NCT06429735 is a NA study of Amyotrophic Lateral Sclerosis and Cervical Spinal Cord Injury that is actively recruiting participants, run by Neuralink. The registered enrollment target is 15 participants, below the 898-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06429735, a NA study of Amyotrophic Lateral Sclerosis and Cervical Spinal Cord Injury, is actively recruiting participants, sponsored by Neuralink.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 2
- Study locations
Study Summary
The PRIME Study is a first-in-human early feasibility study to evaluate the initial clinical safety and device functionality of the Neuralink N1 Implant and R1 Robot device designs in participants with tetraparesis or tetraplegia. The N1 Implant is a skull-mounted, wireless, rechargeable implant connected to electrode threads that are implanted in the brain by the R1 Robot, a robotic electrode thread inserter.
Conditions Studied
Interventions
- DEVICE N1 Implant
- DEVICE R1 Robot
Study Locations (2)
Arizona
- Barrow Neurological Institute - Phoenix
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2024-01-09 |
| Est. Completion | 2031-01 |
| Phase | NA |
What NCT06429735 shows while recruiting
NCT06429735 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 898-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (98% lower).
The record links to 6 conditions, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which N1 Implant is the first listed.
NCT06429735 reports a single indexed study location in Arizona, Florida.
Frequently Asked Questions
What is clinical trial NCT06429735 about?
NCT06429735 is a clinical study titled "Precise Robotically IMplanted Brain-Computer InterfacE". The PRIME Study is a first-in-human early feasibility study to evaluate the initial clinical safety and device functionality of the Neuralink N1 Implant and R1 Robot device designs in participants with tetraparesis or tetraplegia. The N1 Implant is a skull-mounted, wireless, rechargeable implant con...
What is the current status of trial NCT06429735?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2024-01-09. Estimated completion is 2031-01.
What conditions does trial NCT06429735 study?
This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis, Cervical Spinal Cord Injury, Tetraplegia/Tetraparesis, Quadriplegia, Quadriplegia/Tetraplegia.
What interventions are being tested in trial NCT06429735?
The interventions under investigation include: N1 Implant (DEVICE), R1 Robot (DEVICE).
Who is sponsoring clinical trial NCT06429735?
This trial is sponsored by Neuralink, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06429735 being conducted?
This trial has 2 study locations across Arizona, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amyotrophic Lateral Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06429735's enrollment target sits among peer trials
15 86th of 102 higher than 17 of 102 other Amyotrophic Lateral Sclerosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Amyotrophic Lateral Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Assessing Perceptual Effects of Interactive Tasks
RECRUITING · NA
-
Spinal Cord Associative Plasticity for ALS
RECRUITING · NA
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
RECRUITING · NA
-
Oral Intake of Enteral Nutrition Formula Preceding Placement and Feeding Via GTube and Its Impact on Formula Intolerance in pALS
RECRUITING · NA
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI